Literature DB >> 1417548

Interactions between light and vitreous fluid substitutes.

C Azzolini1, F Docchio, R Brancato, G Trabucchi.   

Abstract

To determine the interactions between light and vitreous fluid substitutes, we studied the absorption and fluorescence properties of the following fluids that are commonly used in vitreoretinal surgery: Ringer's solution, balanced salt citrate-buffered solution, balanced salt bicarbonate-buffered solution, hydroxypropyl methylcellulose ophthalmic solution, hyaluronate sodium, perfluorocarbons, silicone oil, and fluorosilicone oil. The absorption spectra for all the fluids peaked in the UV-C (reference range <280 nm) and UV-B (reference range from 315 to 280 nm) regions of the spectrum, with little or no absorption in the visible region of the spectrum (from 400 to 700 nm). Emission of almost all of the fluids occurred mainly in the 300- to 360-nm region, with fairly low-quantum efficiency. The limited light absorption properties of the fluids calls for caution during transpupillary and intraocular laser photocoagulation to avoid excessive retinal damage, mainly when the laser power is increased during treatment. Transmission of incoherent light (environmental and ophthalmic artificial light) through highly transparent vitreous fluid substitutes may lead in time to dangerous light exposure, particularly in aphakic eyes. The emitted fluorescence in these fluids generates a minimal risk of long-term damage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417548     DOI: 10.1001/archopht.1992.01080220130034

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  12 in total

1.  Visual loss after silicone oil removal.

Authors:  E N Herbert; S H M Liew; T H Williamson
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

2.  Central scotoma associated with intraocular silicone oil tamponade develops before oil removal.

Authors:  E N Herbert; M Habib; D Steel; T H Williamson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-27       Impact factor: 3.117

3.  Investigation of albumin-derived perfluorocarbon-based capsules by holographic optical trapping.

Authors:  Jannis Köhler; Jegor Ruschke; Katja Bettina Ferenz; Cemal Esen; Michael Kirsch; Andreas Ostendorf
Journal:  Biomed Opt Express       Date:  2018-01-23       Impact factor: 3.732

4.  Endophotocoagulation through perfluorodecalin in rabbit eyes.

Authors:  C Azzolini; R Brancato; G Trabucchi; F Camesasca; M Codenotti; M Verdi
Journal:  Int Ophthalmol       Date:  1994       Impact factor: 2.031

Review 5.  [Visual acuity reduction and silicone oil tamponade].

Authors:  Armin Wolf; Mario R Romano; Christos Haritoglou
Journal:  Ophthalmologie       Date:  2022-08-02

6.  Vision loss associated with the use and removal of intraocular silicone oil.

Authors:  Patrick D Williams; Christopher G Fuller; Ingrid U Scott; Dwain G Fuller; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2008-12

7.  Vitreous laser absorption following fluorescein angiography in diabetic patients.

Authors:  C Azzolini; S Fantaguzzi; R Brancato; F Docchio; F Bandello; L Guarisco
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

8.  The incidence of unexplained visual loss following removal of silicone oil.

Authors:  R Moya; A Chandra; P J Banerjee; D Tsouris; N Ahmad; D G Charteris
Journal:  Eye (Lond)       Date:  2015-08-07       Impact factor: 3.775

9.  Foveal light exposure is increased at the time of removal of silicone oil with the potential for phototoxicity.

Authors:  Mahmut Dogramaci; Katie Williams; Ed Lee; Tom H Williamson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-06       Impact factor: 3.117

Review 10.  Vitreous substitutes: the present and the future.

Authors:  Simone Donati; Simona Maria Caprani; Giulia Airaghi; Riccardo Vinciguerra; Luigi Bartalena; Francesco Testa; Cesare Mariotti; Giovanni Porta; Francesca Simonelli; Claudio Azzolini
Journal:  Biomed Res Int       Date:  2014-05-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.